We are live on ! Find out more
FCMV

Foresite Capital Management V Portfolio holdings

AUM $271M
1-Year Est. Return 309.87%
This Fund
S&P 500
This Quarter Est. Return
+69.24%
1 Year Est. Return
+309.87%
3 Year Est. Return
+356.88%
5 Year Est. Return
+250.56%
10 Year Est. Return
–
AUM
$271M
AUM Growth
+$107M
Cap. Flow
+$28.2M
Cap. Flow %
10.42%
Top 10 Hldgs %
100%
Holding
10
New
3
Increased
3
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
EIKN
Eikon Therapeutics
EIKN
+$17.6M
2
HIMS icon
Hims & Hers Health
HIMS
+$11M
3
IRON icon
Disc Medicine
IRON
+$5.2M
4
PHVS icon
Pharvaris
PHVS
+$5.18M
5
NRIX icon
Nurix Therapeutics
NRIX
+$4.39M

Top Sells

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$15.4M
2
MAZE
Maze Therapeutics
MAZE
+$2.67M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALMS
1
Alumis Inc
ALMS
$3.65B
$130M 47.94%
5,896,995
+117,647
+2% +$2.94M
CGON icon
2
CG Oncology
CGON
$6.34B
$68M 25.08%
1,004,050
– –
IRON icon
3
Disc Medicine
IRON
$2.91B
$23.9M 8.83%
374,069
+75,000
+25% +$5.2M
HIMS icon
4
Hims & Hers Health
HIMS
$7.6B
$15.3M 5.65%
738,151
+465,000
+170% +$11M
EIKN
5
Eikon Therapeutics
EIKN
$529M
$14M 5.15%
+1,318,983
New +$17.6M
LYEL icon
6
Lyell Immunopharma
LYEL
$326M
$9.57M 3.53%
477,078
– –
PHVS icon
7
Pharvaris
PHVS
$2.44B
$5.48M 2.02%
+194,125
New +$5.18M
NRIX icon
8
Nurix Therapeutics
NRIX
$2.4B
$4.11M 1.52%
+265,000
New +$4.39M
MAZE
9
Maze Therapeutics
MAZE
$1.56B
$773K 0.29%
25,905
-60,386
-70% -$2.67M
NTRA icon
10
Natera
NTRA
$38.9B
– –
-67,356
Closed -$15.4M

Similar funds

MAM
Mullooly Asset Management Wall Township, New Jersey $271M AUM 16.93% 1-Year Est. Return
SWM
Sculati Wealth Management Bloomfield Hills, Michigan $271M AUM 17.23% 1-Year Est. Return
SCG
Sonata Capital Group Seattle, Washington $271M AUM 14.66% 1-Year Est. Return
MLM
Mount Lucas Management Newtown, Pennsylvania $271M AUM 25.49% 1-Year Est. Return
PFG
Prosperity Financial Group San Ramon, California $271M AUM 30.27% 1-Year Est. Return
MCM
Moerus Capital Management New York $271M AUM 58.78% 1-Year Est. Return
RP
Ravenswood Partners Mclean, Virginia $271M AUM
PCM
Punch Card Management Winter Park, Florida $271M AUM 11.49% 1-Year Est. Return

Foresite Capital Management V's Q1 2026 Portfolio in Review

As of Q1 2026, Foresite Capital Management V held 10 positions worth $271M, up 65% from $164M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management V deployed $28.2M of net new capital in Q1 2026, opening 3 new positions and adding to 3 existing holdings. Its largest new stake was Eikon Therapeutics: 1,318,983 shares worth $14M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Maze Therapeutics, an estimated $2.67M trimmed.

  • Foresite Capital Management V's largest Q1 2026 buy was Eikon Therapeutics: 1,318,983 shares worth $14M.
  • Foresite Capital Management V added most to Hims & Hers Health in Q1 2026, an estimated $11M increase.
  • Foresite Capital Management V's biggest Q1 2026 reduction was Maze Therapeutics, cutting an estimated $2.67M.
  • Foresite Capital Management V fully exited Natera in Q1 2026, selling an estimated $15.4M.
  • Foresite Capital Management V's ten largest holdings make up 100% of its $271M portfolio in Q1 2026.
  • Foresite Capital Management V opened 3 new positions and closed 1 in Q1 2026.
  • Foresite Capital Management V's portfolio value rose 65% quarter-over-quarter to $271M.

Based on Foresite Capital Management V's 13F filing for Q1 2026, filed 15 May 2026.